Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Zimmer Biomet Holdings (DE:ZIM)
FRANKFURT:ZIM
RESEARCH TOOLSreports
Zimmer Biomet Holdings (ZIM) Stock Price & Analysis
1 Followers
ZIM Stock Chart & Stats
Day’s Range€0 - €0
52-Week Range€96.76 - €133.12
Previous Close€116.25
Volume0.00
Average Volume (3M)10.00
Market Cap
€23.93B
Enterprise Value€28.98B
Total Cash (Recent Filing)$415.80M
Total Debt (Recent Filing)$5.77B
Price to Earnings (P/E)N/A
Beta0.49
Next Earnings
May 02, 2024EPS Estimate
€1.77Last Dividend Ex-Date
Mar 27, 2024Dividend Yield0.77%
Share Statistics
EPS (TTM)N/A
Shares Outstanding205,084,022
10 Day Avg. Volume0
30 Day Avg. Volume10
Standard DeviationN/A
R-SquaredN/A
AlphaN/A
Financial Highlights & Ratios
Price to Book (P/B)-21.29
Price to Sales (P/S)3.23
Price to Cash Flow (P/CF)10.80
P/FCF Ratio10.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue3.92
Enterprise Value/Gross Profit5.46
Enterprise Value/Ebitda25.58
Forecast
1Y Price Target
€126.87Price Target Upside9.13% Upside
Rating ConsensusHold
Number of Analyst Covering17
Zimmer Biomet Holdings News
Bulls Say, Bears Say
Bulls Say
Innovation And Growth ProjectionsThe introduction of the Persona OsseoTi cementless knee implant and the Persona IQ implant's NTAP approval underscore ZBH's commitment to innovation, potentially driving market growth and meeting 2024 guidance targets.
Market Expansion StrategyZBH's strategic move to acquire VIMS, a visualization systems designer for laparoscopy and arthroscopy, aligns with its vision to broaden its market presence and enhance its technological portfolio.
Product Clearance And Market OpportunityWith the FDA's 510(k) clearance, ZBH's ROSA Shoulder System is set to revolutionize shoulder replacement surgery as the first robotic system of its kind, catering to a growing U.S. market expected to reach $1.2 billion.
Bears Say
Financial PerformanceHigh net debt of $6,810 million suggests significant financial leverage.
Growth ConcernsThe shortfall in U.S. Ortho and relatively flat expectations for Rosa system growth has raised concerns among investors about management's ambitious growth guidance.
Market ShareZBH losing share to 36.9% from 38.0% year over year could signal competitive challenges.
---
Options Prices
Currently, No data available
---
Ownership Overview
0.00% Insiders
0.00% Mutual Funds
0.87% Other Institutional Investors
99.13% Public Companies and
Individual Investors
ZIM FAQ
What was Zimmer Biomet Holdings’s price range in the past 12 months?
Zimmer Biomet Holdings lowest stock price was €96.76 and its highest was €133.12 in the past 12 months.
What is Zimmer Biomet Holdings’s market cap?
Currently, no data Available
When is Zimmer Biomet Holdings’s upcoming earnings report date?
Zimmer Biomet Holdings’s upcoming earnings report date is May 02, 2024 which is in 14 days.
How were Zimmer Biomet Holdings’s earnings last quarter?
Zimmer Biomet Holdings released its earnings results on Feb 08, 2024. The company reported €2.072 earnings per share for the quarter, beating the consensus estimate of €2.029 by €0.043.
Is Zimmer Biomet Holdings overvalued?
According to Wall Street analysts Zimmer Biomet Holdings’s price is currently Undervalued.
Does Zimmer Biomet Holdings pay dividends?
Zimmer Biomet Holdings pays a Quarterly dividend of €0.23 which represents an annual dividend yield of 0.77%. See more information on Zimmer Biomet Holdings dividends here
What is Zimmer Biomet Holdings’s EPS estimate?
Zimmer Biomet Holdings’s EPS estimate is €1.77.
How many shares outstanding does Zimmer Biomet Holdings have?
Currently, no data Available
What happened to Zimmer Biomet Holdings’s price movement after its last earnings report?
Zimmer Biomet Holdings reported an EPS of €2.072 in its last earnings report, beating expectations of €2.029. Following the earnings report the stock price went down -0.127%.
Which hedge fund is a major shareholder of Zimmer Biomet Holdings?
Among the largest hedge funds holding Zimmer Biomet Holdings’s share is Dodge & Cox. It holds Zimmer Biomet Holdings’s shares valued at 1B.
---
Zimmer Biomet Holdings Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Hold
Average Price Target:
€126.87 (9.13% Upside)
€126.87 (9.13% Upside)
Blogger Sentiment
Bullish
DE:ZIM Sentiment 100%
Sector Average 70%
Sector Average 70%
Insider Transactions
Sold Shares
Worth $3.4M over
the Last 3 Months
the Last 3 Months
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Positive
20 days / 200 days
Momentum
-7.06%
12-Months-Change
Fundamentals
Return on Equity
8.36%
Trailing 12-Months
Asset Growth
2.05%
Trailing 12-Months
Company Description
Zimmer Biomet Holdings
Zimmer Biomet Holdings, Inc. is a musculoskeletal healthcare company. The company engages in designing, manufacturing and marketing orthopedic reconstructive products; biologics, sports medicine, extremities and trauma products; spine, dental implants, bone healing, craniomaxillofacial and thoracic products; and related surgical products.
---
ZIM Earnings Call
Q4 2024
0:00 / 0:00
---
ZIM Net sales Breakdown
41.09% Knees
26.60% Hips
23.70% S.E.T
8.60% Other
---
ZIM Stock 12 Months Forecast
Average Price Target
€126.87
▲(9.13% Upside)
Technical Analysis
Zimmer Biomet Holdings
―
Abbott Labs
―
Johnson & Johnson
―
Medtronic
―
Baxter International
―
Best Analysts Covering ZIM
1 Year
1 Year Success Rate
29/41 ratings generated profit
1 Year Average Return
+6.91%
assigned a buy rating 8 months ago
Copying Steven Lichtman's trades and holding each position for 1 Year would result in 70.73% of your transactions generating a profit, with an average return of +6.91% per trade.
---